Driehaus Capital Management LLC Boosts Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Driehaus Capital Management LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 2.9% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 100,988 shares of the biotechnology company’s stock after purchasing an additional 2,857 shares during the period. Driehaus Capital Management LLC’s holdings in Axon Enterprise were worth $9,409,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the company. Crossmark Global Holdings Inc. grew its stake in shares of Axon Enterprise by 1.6% in the 2nd quarter. Crossmark Global Holdings Inc. now owns 6,400 shares of the biotechnology company’s stock valued at $597,000 after buying an additional 100 shares during the period. Atria Wealth Solutions Inc. grew its stake in shares of Axon Enterprise by 5.7% in the 2nd quarter. Atria Wealth Solutions Inc. now owns 2,168 shares of the biotechnology company’s stock valued at $202,000 after buying an additional 116 shares during the period. National Bank of Canada FI grew its stake in shares of Axon Enterprise by 20.7% in the 2nd quarter. National Bank of Canada FI now owns 806 shares of the biotechnology company’s stock valued at $75,000 after buying an additional 138 shares during the period. Cetera Investment Advisers grew its stake in shares of Axon Enterprise by 5.9% in the 2nd quarter. Cetera Investment Advisers now owns 2,979 shares of the biotechnology company’s stock valued at $278,000 after buying an additional 165 shares during the period. Finally, Raymond James Trust N.A. lifted its holdings in shares of Axon Enterprise by 4.7% in the 1st quarter. Raymond James Trust N.A. now owns 3,753 shares of the biotechnology company’s stock worth $517,000 after acquiring an additional 168 shares during the last quarter. Hedge funds and other institutional investors own 78.44% of the company’s stock.

Insiders Place Their Bets

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 643 shares of the stock in a transaction that occurred on Monday, December 5th. The shares were sold at an average price of $186.40, for a total transaction of $119,855.20. Following the sale, the insider now directly owns 206,219 shares in the company, valued at approximately $38,439,221.60. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, insider Jeffrey C. Kunins sold 643 shares of the firm’s stock in a transaction on Monday, December 5th. The shares were sold at an average price of $186.40, for a total value of $119,855.20. Following the sale, the insider now directly owns 206,219 shares in the company, valued at approximately $38,439,221.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Joshua Isner sold 1,556 shares of the firm’s stock in a transaction on Monday, December 5th. The shares were sold at an average price of $186.40, for a total transaction of $290,038.40. Following the completion of the sale, the chief operating officer now owns 247,877 shares in the company, valued at $46,204,272.80. The disclosure for this sale can be found here. Insiders have sold a total of 19,210 shares of company stock worth $2,947,314 in the last ninety days. 6.90% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have recently commented on AXON. Robert W. Baird upped their price objective on shares of Axon Enterprise to $170.00 in a report on Tuesday, November 15th. Barclays began coverage on shares of Axon Enterprise in a report on Thursday, September 15th. They issued an “overweight” rating and a $147.00 price objective on the stock. Northland Securities upped their price objective on shares of Axon Enterprise from $140.00 to $160.00 in a report on Wednesday, November 9th. Credit Suisse Group upped their price objective on shares of Axon Enterprise from $142.00 to $152.00 and gave the stock an “outperform” rating in a report on Wednesday, November 9th. Finally, StockNews.com began coverage on shares of Axon Enterprise in a report on Wednesday, October 12th. They issued a “hold” rating on the stock. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $168.25.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $171.71 on Friday. The firm has a market cap of $12.22 billion, a PE ratio of 118.42 and a beta of 0.75. Axon Enterprise, Inc. has a 52-week low of $82.49 and a 52-week high of $193.85. The company has a quick ratio of 2.39, a current ratio of 2.79 and a debt-to-equity ratio of 0.01. The company’s 50 day moving average is $157.33 and its two-hundred day moving average is $129.94.

About Axon Enterprise

(Get Rating)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.